SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus.

[1]  C. Langefeld,et al.  Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry , 2023, Scientific Reports.

[2]  Jian Huang,et al.  Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis , 2023, Journal of Translational Medicine.

[3]  Xiaodong Liu,et al.  Establishment and analysis of a disease risk prediction model for the systemic lupus erythematosus with random forest , 2022, Frontiers in Immunology.

[4]  C. Terao,et al.  Distinct transcriptome architectures underlying lupus establishment and exacerbation , 2022, Cell.

[5]  J. Kahlenberg,et al.  Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches. , 2022, Annual review of medicine.

[6]  S. Caielli,et al.  Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond. , 2022, Annual review of immunology.

[7]  T. Hsiao,et al.  Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia , 2021, Schizophrenia Research.

[8]  M. Gerstein,et al.  Illuminating links between cis-regulators and trans-acting variants in the human prefrontal cortex , 2021, bioRxiv.

[9]  Sina A. Gharib,et al.  Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression , 2021, Nature Genetics.

[10]  V. Pascual,et al.  Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE , 2021, Cell.

[11]  Y. Okada,et al.  Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases , 2021, Cell.

[12]  Jiangshan J. Shen,et al.  Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups , 2021, Nature Communications.

[13]  D. Gladman,et al.  The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus , 2021, Arthritis Research & Therapy.

[14]  M. Weirauch,et al.  Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus , 2020, Annals of the Rheumatic Diseases.

[15]  T. Niewold,et al.  Type I interferon in the pathogenesis of systemic lupus erythematosus. , 2020, Current opinion in immunology.

[16]  Jie Jin,et al.  PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience , 2020, Hematological oncology.

[17]  M. Weirauch,et al.  SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression , 2020, bioRxiv.

[18]  Philip D. Harvey,et al.  S173. GENOME-WIDE ASSOCIATION STUDIES OF SCHIZOPHRENIA AND BIPOLAR DISORDER IN A DIVERSE COHORT OF US VETERANS , 2020, Biological Psychiatry.

[19]  S. Kotenko,et al.  Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus , 2020, Proceedings of the National Academy of Sciences.

[20]  F. Houssiau,et al.  IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study , 2019, Annals of the rheumatic diseases.

[21]  Meenakshi S Kagda,et al.  New developments on the Encyclopedia of DNA Elements (ENCODE) data portal , 2019, Nucleic Acids Res..

[22]  L. Rönnblom,et al.  Interferon pathway in SLE: one key to unlocking the mystery of the disease , 2019, Lupus Science & Medicine.

[23]  Birgit Sikkema-Raddatz,et al.  Improving the diagnostic yield of exome- sequencing by predicting gene–phenotype associations using large-scale gene expression analysis , 2019, Nature Communications.

[24]  Stephen Burgess,et al.  PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations , 2019, Bioinform..

[25]  Lin Hou,et al.  Identification of trans-eQTLs using mediation analysis with multiple mediators , 2019, BMC Bioinformatics.

[26]  M. Petri,et al.  Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression , 2018, Arthritis & rheumatology.

[27]  Y. Kamatani,et al.  Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. , 2018, Schizophrenia bulletin.

[28]  P. Boutros,et al.  Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19 , 2018, Cell.

[29]  Jay A. Montgomery,et al.  Multi-ethnic genome-wide association study for atrial fibrillation , 2018, Nature Genetics.

[30]  S. Djurovic,et al.  Genetic Overlap Between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms , 2018, Schizophrenia bulletin.

[31]  G. Sims,et al.  Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus , 2018, Lupus Science & Medicine.

[32]  Liangdan Sun,et al.  Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese population , 2017, Annals of the rheumatic diseases.

[33]  P. Gregersen,et al.  Transancestral mapping and genetic load in systemic lupus erythematosus , 2017, Nature Communications.

[34]  P. Gaffney,et al.  Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus , 2016, Nature Genetics.

[35]  Julie Ducreux,et al.  Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study , 2016, Rheumatology.

[36]  Virginia Pascual,et al.  Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients , 2016, Cell.

[37]  K. Kalunian,et al.  Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study , 2016, Annals of the rheumatic diseases.

[38]  R. Silverman,et al.  Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses , 2016, Proceedings of the National Academy of Sciences.

[39]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[40]  Marco Y. Hein,et al.  A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances , 2015, Cell.

[41]  E. Morand,et al.  Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) , 2015, Annals of the rheumatic diseases.

[42]  H. Blum,et al.  Tumor Necrosis Factor Alpha and Insulin-Like Growth Factor 1 Induced Modifications of the Gene Expression Kinetics of Differentiating Skeletal Muscle Cells , 2015, PloS one.

[43]  J. Rioux,et al.  Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus , 2015, Nature Genetics.

[44]  R. Maciuca,et al.  A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE) , 2015, Annals of the rheumatic diseases.

[45]  Philip A. Ewels,et al.  Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C , 2015, Nature Genetics.

[46]  Herren Wu,et al.  Molecular basis for antagonistic activity of anifrolumab, an anti-interferon–α receptor 1 antibody , 2015, mAbs.

[47]  Neva C. Durand,et al.  A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.

[48]  Lude Franke,et al.  Mediation Analysis Demonstrates That Trans-eQTLs Are Often Explained by Cis-Mediation: A Genome-Wide Analysis among 1,800 South Asians , 2014, PLoS genetics.

[49]  M. Heitkemper,et al.  Sleep quality, BDNF genotype and gene expression in individuals with chronic abdominal pain , 2014, BMC Medical Genomics.

[50]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[51]  K. Nagata,et al.  Silencing of IFN-stimulated gene transcription is regulated by histone H1 and its chaperone TAF-I , 2014, Nucleic acids research.

[52]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[53]  L. Ivashkiv,et al.  Regulation of type I interferon responses , 2013, Nature Reviews Immunology.

[54]  A. Julià,et al.  Genome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis , 2013, BMC Genomics.

[55]  D. Rao,et al.  The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN , 2013, Front. Genet..

[56]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[57]  Yong Cui,et al.  Genetic susceptibility to SLE: recent progress from GWAS. , 2013, Journal of autoimmunity.

[58]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[59]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[60]  Yusuke Nakamura,et al.  Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene , 2012, PLoS genetics.

[61]  P. Gaffney,et al.  Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. , 2012, American journal of human genetics.

[62]  J. Piette,et al.  Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.

[63]  Jacek Majewski,et al.  The study of eQTL variations by RNA-seq: from SNPs to phenotypes. , 2011, Trends in genetics : TIG.

[64]  B. Tsao,et al.  Genetic susceptibility to systemic lupus erythematosus in the genomic era , 2010, Nature Reviews Rheumatology.

[65]  Annette Lee,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[66]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[67]  Z. Amoura,et al.  IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model , 2009, Proceedings of the National Academy of Sciences.

[68]  L. Liang,et al.  Mapping complex disease traits with global gene expression , 2009, Nature Reviews Genetics.

[69]  J. Shay,et al.  SGNP: An Essential Stress Granule/Nucleolar Protein Potentially Involved in 5.8s rRNA Processing/Transport , 2008, PloS one.

[70]  Scott A. Rifkin,et al.  Revealing the architecture of gene regulation: the promise of eQTL studies. , 2008, Trends in genetics : TIG.

[71]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[72]  D. Furst,et al.  Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[73]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[74]  Marta E Alarcón-Riquelme,et al.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.

[75]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[76]  L. Platanias.  Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[77]  Marta E Alarcón-Riquelme,et al.  Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. , 2005, Arthritis and rheumatism.

[78]  J. Kere,et al.  Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. , 2005, American journal of human genetics.

[79]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[80]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R. Friedman,et al.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. , 1982, Science.

[82]  T. Schnitzer,et al.  Serum interferon levels in patients with systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[83]  C. Gordon,et al.  Systemic lupus erythematosus , 2016, Nature Reviews Disease Primers.